Articles in section Licensing
| << Joint Venture | 502 articles | Mergers & Acquisitions >> |
| << Previous | Pages 1 ..2 3 4 5 6 7 .. 51 | Next >> |
-
Ironwood Begins to Rebolster its Pipeline with Cour’s Rare Disease Drug
-
Aridis Pharmaceuticals Licenses AstraZeneca’s late-stage monoclonal antibody, survatoxumab
-
Biogen Licenses InnoCare’s Orelabrutinib to Strengthen Multiple Sclerosis Presence
-
Novo Nordisk and Heartseed Enter into Agreement to Develop Cell therapy for Heart Failure
-
Akebia Expands Renal Disease Portfolio with Cyclerion’s Praliciguat
-
Genentech and Pieris Collaborate on Respiratory and Ophthalmology Therapies
-
BMS Bolsters Pipeline with Two Billion-Dollar Deals
-
Pfizer Pledges up to US$4.4 B for Myovant’s Orgovyx
-
Merck KGaA Expands Head and Neck Cancer Therapy Portfolio with Debiopharm’s Xevinapant
-
Boston Pharmaceuticals In-Licenses Another Two Programmes from GSK
RSS